MarketPulse
R

$RZLT

3 articles found
0 positive
2 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··The Portnoy Law Firm

Rezolute Stock Plunges 87% After Failed Drug Trial, Securities Probe Launched

Rezolute's lead drug candidate failed Phase 3 trials, triggering massive stock collapse and securities fraud investigation by Portnoy Law Firm.
RZLTsecurities fraud investigationstock price collapse
GlobeNewswire Inc.GlobeNewswire Inc.··Na

XOMA Royalty Surges on 68% Royalty Growth and Aggressive Portfolio Expansion

XOMA Royalty reports $50M+ cash receipts in 2025, with royalties up 68% YoY. Company adds 22 assets, completes seven acquisitions, and repurchases $16M in shares.
DAWNRZLTGOSSZVRAMIRM+3acquisitionsshare buyback
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Rezolute to Present Rare Disease Pipeline at Citizens Life Sciences Conference

Rezolute to present ersodetug antibody therapy program at Citizens Life Sciences Conference in Miami, March 10-11, 2026, with direct investor meetings.
RZLTclinical trialsinvestor conference